Cogent Biosciences Inc - COGT Net earnings per one share for the last twelve months

Cogent Biosciences Inc (COGT) - corporate logo

Cogent Biosciences (COGT) develops targeted therapies for rare pathologies, ensuring high margins due to a lack of competitors. The annual earnings per share growth over 12 months, which forms this chart via GURU.Markets quotes, stands at 0.70. The issuer attracts top oncologists with generous stock options and R&D budgets, while breakthrough drugs for genetic mutations are currently undergoing testing and have not yet generated mass revenue.

COGT: cogentbio.com Net earnings per share for the last 12 months 02/11/2024 - 11/17/2026

Cogent Biosciences - analytical breakdowns and key metrics (COGT)

- issuer market value details:
Fundamental company valuation:COGT - Cogent Biosciences Inc
Brand item of Cogent Corp

Investors assess the fundamental resilience of a business through earnings per share dynamics, utilizing the calculated change in TTM EPS to identify real capital growth rates. For Cogent Biosciences (COGT), which depends on FDA verdicts and clinical trial success, the history of YoY EPS (TTM) percentage growth serves as an indicator of the extent to which market expectations for the oncology ecosystem are validated by actual financial performance.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)